Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1159/000509483 http://scihub22266oqcxt.onion/10.1159/000509483 32599589!7360507!32599589     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cardiorenal+Med 2020 ; 10 (5): 277-287 Nephropedia Template TP {{tp|p=32599589|t=2020. Weathering the Cytokine Storm in COVID-19: Therapeutic Implications |pdf=|usr=}}{{32599589}} gab.com Text Weathering the Cytokine Storm in COVID-19: Therapeutic Implications JO: Cardiorenal Med http://www.kidney.de/pget.php?&tw=1&pmid=32599589 #FOAvip BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently emerged in Wuhan, Hubei-China, as responsible for the coronavirus disease 2019 (COVID-19) and then spread rapidly worldwide. While most individuals remain asymptomatic or develop only mild symptoms, approximately 5% develop severe forms of COVID-19 characterized by acute respiratory distress syndrome (ARDS) and multiple-organ failure (MOF) that usually require intensive-care support and often yield a poor prognosis. SUMMARY: The pathophysiology of COVID-19 is far from being completely understood, and the lack of effective treatments leads to a sense of urgency to develop new therapeutic strategies based on pathophysiological assumptions. The exaggerated cytokine release in response to viral infection, a condition known as cytokine release syndrome (CRS) or cytokine storm, is emerging as the mechanism leading to ARDS and MOF in COVID-19, thus endorsing the hypothesis that properly timed anti-inflammatory therapeutic strategies could improve patients' clinical outcomes and prognosis. Key Messages: The objective of this article is to explore and comment on the potential role of the promising immunomodulatory therapies using pharmacological and nonpharmacological approaches to overcome the dysregulated proinflammatory response in COVID-19. Twit Text FOAVip Weathering the Cytokine Storm in COVID-19: Therapeutic Implications ????Cardiorenal Med http://www.kidney.de/pget.php?&tw=1&pmid=32599589 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32599589 #FOAvip English Wikipedia <ref>{{Cite pmid|32599589}}</ref> Weathering the Cytokine Storm in COVID-19: Therapeutic Implications #MMPMID32599589 Iannaccone G; Scacciavillani R; Del Buono MG; Camilli M; Ronco C; Lavie CJ; Abbate A; Crea F; Massetti M; Aspromonte N Cardiorenal Med 2020[]; 10 (5): 277-287 PMID32599589show ga BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently emerged in Wuhan, Hubei-China, as responsible for the coronavirus disease 2019 (COVID-19) and then spread rapidly worldwide. While most individuals remain asymptomatic or develop only mild symptoms, approximately 5% develop severe forms of COVID-19 characterized by acute respiratory distress syndrome (ARDS) and multiple-organ failure (MOF) that usually require intensive-care support and often yield a poor prognosis. SUMMARY: The pathophysiology of COVID-19 is far from being completely understood, and the lack of effective treatments leads to a sense of urgency to develop new therapeutic strategies based on pathophysiological assumptions. The exaggerated cytokine release in response to viral infection, a condition known as cytokine release syndrome (CRS) or cytokine storm, is emerging as the mechanism leading to ARDS and MOF in COVID-19, thus endorsing the hypothesis that properly timed anti-inflammatory therapeutic strategies could improve patients' clinical outcomes and prognosis. Key Messages: The objective of this article is to explore and comment on the potential role of the promising immunomodulatory therapies using pharmacological and nonpharmacological approaches to overcome the dysregulated proinflammatory response in COVID-19. |Adrenal Cortex Hormones/therapeutic use[MESH] |Antibodies, Monoclonal, Humanized/therapeutic use[MESH] |Betacoronavirus[MESH] |CCR5 Receptor Antagonists/therapeutic use[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19 Serotherapy[MESH] |Chloroquine/therapeutic use[MESH] |Coronavirus Infections/drug therapy/immunology/*therapy[MESH] |Cytokine Release Syndrome/immunology/*therapy[MESH] |Enzyme Inhibitors/therapeutic use[MESH] |Extracorporeal Membrane Oxygenation[MESH] |HIV Antibodies/therapeutic use[MESH] |Hemoperfusion[MESH] |Humans[MESH] |Hydroxychloroquine/therapeutic use[MESH] |Immunization, Passive[MESH] |Immunoglobulins, Intravenous/therapeutic use[MESH] |Immunologic Factors/therapeutic use[MESH] |Immunomodulation[MESH] |Interleukin 1 Receptor Antagonist Protein/therapeutic use[MESH] |Janus Kinase Inhibitors/therapeutic use[MESH] |Lung Injury/immunology/therapy[MESH] |Mesenchymal Stem Cell Transplantation[MESH] |Multiple Organ Failure[MESH] |Pandemics[MESH] |Plasma Exchange[MESH] |Plasmapheresis[MESH] |Pneumonia, Viral/immunology/*therapy[MESH] |Receptors, Interleukin-6/antagonists & inhibitors[MESH] |Respiratory Distress Syndrome/immunology/*therapy[MESH] |SARS-CoV-2[MESH]Weathering the Cytokine Storm in COVID-19: Therapeutic Implications (epmc).pdf DeepDyve Pubget Overpricing